TREM2 and Alzheimer disease: Sporadic AD patients carrying TREM2 risk variants have a higher percentage of dystrophic microglia, a phenomenon recapitulated in preclinical studies where TREM2 deficiency leads to microglial accumulation of ApoE and impaired microgliosis [22, 23].